Pharmacotherapy of obesity: an update.

Sunita Schurgin, Richard D Siegel
{"title":"Pharmacotherapy of obesity: an update.","authors":"Sunita Schurgin,&nbsp;Richard D Siegel","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>There has been an epidemic of obesity in the last decade. In spite of the rising numbers of people who are overweight and obese, medical treatment of obesity is currently where medical treatment of hypertension was in the 1950s with only two Food and Drug Administration-approved medications for chronic weight loss and maintenance, sibutramine and orlistat. This article reviews these medications and others currently being used for weight loss and weight maintenance. Available medications for obesity include drugs that affect caloric intake and appetite and alter energy expenditure and nutrient absorption, as well as some with an unclear mechanism of action at present. Dozens of drugs in different phases of clinical investigation could be available in the next decade.</p>","PeriodicalId":83835,"journal":{"name":"Nutrition in clinical care : an official publication of Tufts University","volume":"6 1","pages":"27-37"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nutrition in clinical care : an official publication of Tufts University","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

There has been an epidemic of obesity in the last decade. In spite of the rising numbers of people who are overweight and obese, medical treatment of obesity is currently where medical treatment of hypertension was in the 1950s with only two Food and Drug Administration-approved medications for chronic weight loss and maintenance, sibutramine and orlistat. This article reviews these medications and others currently being used for weight loss and weight maintenance. Available medications for obesity include drugs that affect caloric intake and appetite and alter energy expenditure and nutrient absorption, as well as some with an unclear mechanism of action at present. Dozens of drugs in different phases of clinical investigation could be available in the next decade.

肥胖症的药物治疗:最新进展。
在过去的十年里,肥胖一直是一种流行病。尽管超重和肥胖的人越来越多,但目前对肥胖的医学治疗就像20世纪50年代对高血压的医学治疗一样,只有两种食品和药物管理局批准的药物用于慢性减肥和维持体重,西布曲明和奥利司他。这篇文章回顾了这些药物和其他目前用于减肥和维持体重的药物。现有的肥胖药物包括影响热量摄入和食欲、改变能量消耗和营养吸收的药物,以及一些目前作用机制尚不清楚的药物。未来十年,数十种处于不同临床研究阶段的药物可能问世。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信